Gynecology & Obstetrics (all articles)
ESSM Position Statement: Sexual Wellbeing After Gender Affirming Surgery.
4 Feb, 2022 | 08:34h | UTCESSM Position Statement “Sexual Wellbeing After Gender Affirming Surgery” – Sexual Medicine
Review: Evaluation and management of vaginitis.
3 Feb, 2022 | 08:37h | UTCEvaluation and Management of Vaginitis – Mayo Clinic Proceedings
Review: Behçet syndrome.
3 Feb, 2022 | 08:29h | UTCBehçet syndrome – Nature Reviews Disease Primers (if the link is paywalled, try this one)
Infographic: Behçet syndrome (if the link is paywalled, try this one)
Related: EULAR recommendations for the management of Behçet’s syndrome
Editorial: Menstruation and Covid-19 vaccination.
2 Feb, 2022 | 08:46h | UTCMenstruation and covid-19 vaccination – The BMJ
News Release: New studies provide reassuring data on menstrual changes after covid-19 vaccination – BMJ
Commentary on Twitter
The findings from two new studies are reassuring: "changes to the menstrual cycle do occur following vaccination, but they are small compared with natural variation and quickly reverse"https://t.co/QFZ4I1U6yd
— The BMJ (@bmj_latest) January 28, 2022
DIC in Pregnancy: Pathophysiology, clinical characteristics, diagnostic scores, and treatments.
2 Feb, 2022 | 08:27h | UTC
Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicenter pooled analysis of 5161 patients.
2 Feb, 2022 | 08:22h | UTC
M-A: Birth outcomes of neonates exposed to marijuana in utero.
2 Feb, 2022 | 08:19h | UTCInvited commentary: Reexamining Risks of Prenatal Cannabis Use—Mounting Evidence and a Call to Action – JAMA Network Open
Commentary on Twitter
This systematic review and meta-analysis found that prenatal marijuana exposure is associated with increases in many adverse neonatal outcomes, including lower birth weight and preterm delivery. @MarchandSurgery @tmcaznews https://t.co/qvWOWu4Dkc
— JAMA Network Open (@JAMANetworkOpen) January 27, 2022
Observational Study: Same-day mastectomy and axillary lymph node dissection seems safe for most patients with breast cancer.
1 Feb, 2022 | 08:38h | UTC
Review: Primary care-based cardiovascular disease risk management after adverse pregnancy outcomes.
1 Feb, 2022 | 08:29h | UTCPrimary Care–Based Cardiovascular Disease Risk Management After Adverse Pregnancy Outcomes: a Narrative Review – Journal of General Internal Medicine (if the link is paywalled, try this one)
See also: thread from the author on Twitter summarizing the article
Related:
AHA Scientific Statement | Adverse Pregnancy Outcomes and Cardiovascular Disease Risk
Cohort Study: Preeclampsia and Cardiovascular Disease
Cohort Study: Cardiovascular Disease After Hypertensive Disorders of Pregnancy Largely Explained by Conventional Cardiovascular Risk Factors (recent studies on the subject)
M-A: The diagnostic accuracy of syndromic management for genital ulcer disease.
1 Feb, 2022 | 08:12h | UTC
M-A: Association of antenatal diet and physical activity–based interventions with gestational weight gain and pregnancy.
1 Feb, 2022 | 08:10h | UTCNews Release: New evidence shows the importance of healthy lifestyle programs in pregnancy – University of Monash
Commentary on Twitter
Systematic review of 117 studies on structured antenatal diet and physical activity lifestyle interventions, associated with reduced gestational weight gain and improved outcomes for mothers and babies; now for implementation into routine care https://t.co/lBFV76lQe2 @helenateede
— JAMA Internal Medicine (@JAMAInternalMed) December 21, 2021
Risk of obstetric anal sphincter injury among women who birth vaginally after a prior cesarean section: A state-wide cohort study.
30 Jan, 2022 | 13:48h | UTCRisk of obstetric anal sphincter injury among women who birth vaginally after a prior caesarean section: A state-wide cohort study – BJOG (link to abstract – $ for full-text)
Cohort Study: Association of preeclampsia and perinatal complications with offspring neurodevelopmental and psychiatric disorders.
30 Jan, 2022 | 13:51h | UTC
Expert Review: Preeclampsia has two phenotypes which require different treatment strategies.
28 Jan, 2022 | 08:15h | UTC
Commentary on Twitter
AJOG Expert Review in Preeclampsia: Preeclampsia has 2 phenotypes which require different treatment strategies https://t.co/qVJU0NBpGf pic.twitter.com/7i1W46pbKd
— AJOG (@AJOG_thegray) December 31, 2021
AAP Report: Some alternative peripartum, neonatal practices carry disease risks.
27 Jan, 2022 | 09:41h | UTCNews Release: Some alternative peripartum, neonatal practices carry disease risks: AAP report – American Academy of Pediatrics
Report: Risks of Infectious Diseases in Newborns Exposed to Alternative Perinatal Practices – Pediatrics
Commentary: Risks Discussed for Alternative Peripartum, Neonatal Practices – HealthDay
Perspective: From vaginal laser treatment to spa breaks – it’s the great menopause gold rush.
27 Jan, 2022 | 09:36h | UTCFrom vaginal laser treatment to spa breaks – it’s the great menopause gold rush – The Guardian
Preconception exposures and adverse pregnancy, birth and postpartum outcomes: Umbrella review of systematic reviews.
27 Jan, 2022 | 09:20h | UTC
Opinion | “The use of polygenic risk scores in pre-implantation genetic testing: an unproven, unethical practice”.
26 Jan, 2022 | 01:52h | UTCCommentary: ‘Unproven and unethical’: experts warn against genetic embryo tests – The Guardian
RCT: Single-dose 1000 mg ertapenem is non-inferior to single-dose 500 mg ceftriaxone for the treatment of gonorrhea.
25 Jan, 2022 | 09:20h | UTCEfficacy of ertapenem, gentamicin, fosfomycin, and ceftriaxone for the treatment of anogenital gonorrhoea (NABOGO): a randomised, non-inferiority trial – The Lancet Infectious Diseases (link to abstract – $ for full-text)
Commentary on Twitter (thread – click for more)
New from @TheLancetInfDis Efficacy of ertapenem, gentamicin, fosfomycin, and ceftriaxone for the treatment of anogenital gonorrhoea (NABOGO): a randomised, non-inferiority trial by @henryjdevries and colleagues https://t.co/K2fw5ORNlm pic.twitter.com/d8wz1Vc41Q
— The Lancet HIV (@TheLancetHIV) January 24, 2022
RCT: Lactic acid gel vs. metronidazole for recurrent bacterial vaginosis in women aged 16 years and over.
24 Jan, 2022 | 08:13h | UTC
Outcome of patients with an ultralow-risk 70-gene signature in the MINDACT trial.
24 Jan, 2022 | 08:08h | UTCOutcome of Patients With an Ultralow-Risk 70-Gene Signature in the MINDACT Trial – Journal of Clinical Oncology (link to abstract – $ for full-text)
Related:
Commentary on Twitter:
In MINDACT, 15% of the pts (n=1000) had an ultra-low 70-gene signature. Although some had tumors >2 cm (20%) & were LN+ (20%), prognosis was outstanding
8-year DMFI 97%
8-year BCSS 99.6%Most of these patients received adj treatment. Did they need it?https://t.co/V9SH2StuQE
— Paolo Tarantino (@PTarantinoMD) January 22, 2022
Practical Guide: Management of bladder pain syndrome.
24 Jan, 2022 | 07:52h | UTCManagement of Bladder Pain Syndrome (BPS): A Practical Guide – Advances in Urology
Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: ASCO-OH (CCO) Guideline Update.
20 Jan, 2022 | 08:57h | UTC
Commentary on Twitter
Out on @JCO_ASCO the new ASCO/OH guidelines for adjuvant bisphosphonates in BC
Important to weight risks and benefits based on the risk profile of the disease, financial toxicity, drug availability, patient preferences, comorbidities & life expectancy. https://t.co/6noyYplALB
— Paolo Tarantino (@PTarantinoMD) January 18, 2022
O-RADS MRI Risk Stratification System: Guide for Assessing Adnexal Lesions from the ACR O-RADS Committee.
20 Jan, 2022 | 08:59h | UTC
Review: Diagnosis and treatment of polycystic ovary syndrome.
20 Jan, 2022 | 08:54h | UTCDiagnosis and Treatment of Polycystic Ovary Syndrome – JAMA (free for a limited period)